In the endometrioid carcinoma samples, frequencies of glycodelin, UEAI–glycodelin, and UEAI-staining positive samples were not statistically different between low (grades 1 and 2) and high (grade 3) grade endometrioid tumors (Table 2). This evidence concerns the gene PAEP and endometrioid adenocarcinoma.